BabCore tincture (liquid extract) formulation comprises a synergistic blend of the four most crucial herbs aimed at combatting Babesiosis. Cryptolepis sanguinolenta exhibits multiple targeted actions effective in treating babesiosis, including antibabesial/antimalarial, and anti-inflammatory properties. Sida acuta plays a protective role in preserving the spleen and liver, organs often affected by babesia, in addition to safeguarding endothelial cells and red blood cells. Furthermore, Sida acuta contributes to countering the anemia commonly associated with babesia infection, while demonstrating antioxidant, anti-inflammatory, and immune-modulatory capabilities. Artemisia annua is renowned for its antiparasitic, antibacterial, anti-inflammatory, and immunomodulatory attributes. Alchornea cordifolia possess antimicrobial properties, and the plant’s constituents have shown to exert anti-inflammatory and immunomodulatory effects. These properties could be beneficial in managing inflammation and supporting the immune response against tick-borne infections.
For optimal efficacy, this formulation is best utilized in combination with the Foundation Formula and Salvia miltorrhiza. Such integration harnesses the complementary actions of these herbs, augmenting the therapeutic approach for addressing Babesiosis. By capitalizing on the distinct strengths of each component, the formulation aims to provide a comprehensive and effective strategy for managing Babesiosis, ultimately enhancing treatment outcomes
